Skip to Content

Join the 'Anthrax Immune Globulin Intravenous' group to help and get support from people like you.

Anthrax Immune Globulin Intravenous News

Anthrax Vaccine Shows Promise in Monkey Trial

Posted 1 Jul 2016 by

FRIDAY, July 1, 2016 – A vaccine made with a component of the bacteria that causes anthrax protected monkeys from the deadly infection in a preliminary trial. Previous research showed that this component – the anthrax capsule – played a pivotal role in providing protection, the researchers said. In this study, the same team of scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) tested a higher dose of the anthrax capsule vaccine in monkeys exposed to lethal inhaled levels of anthrax spores. All the monkeys that received the vaccine survived, while the non-vaccinated monkeys died from anthrax, according to the study published online June 27 in the journal Vaccine. The results suggest that anthrax capsule is a highly effective vaccine ingredient and should be considered for use in future anthrax vaccines, the researchers said. Current anthrax ... Read more

Related support groups: BCG, Prevnar 13, Prevnar, Vivotif Berna, Tetanus Toxoid, Typhoid Vaccine, Live, Pneumococcal 23-polyvalent Vaccine, Pneumovax 23, Vivotif Berna Vaccine, Anthrax, Menactra, Anthrax Prophylaxis, Tice BCG, Pneumococcal 7-Valent Vaccine, Cholera Vaccine, Tetanus Toxoid Adsorbed, Typhoid Vaccine, Inactivated, Meningococcal Polysaccharide Vaccine, Pneumococcal 13-valent Conjugate Vaccine, Typhim Vi

Ask a Question

Further Information

Related Condition Support Groups


Related Drug Support Groups


Anthrax Immune Globulin Intravenous Patient Information at